19 NOVEMBER 2009, BOSTON - Zen Chu (Accelerated
Medical Ventures and CIMIT's Innovation Grand Rounds) recently
testified at the FDA's public hearings on Social Media and Internet (#FDASM).
The FDA is grappling with a number of questions centered around
regulation and accountability for Healthcare and the use of Social
Media, with implications for direct-to-consumer advertising, patient
safety, adverse event reporting, disease management, and new technology
innovation.
The
FDA thought it wise to bring together qualified experts from a wide
range of areas to give testimony. Streaming video available for the next 20 days:http://www.fdasm.com/
I thought Zen had an interesting
testimony, perspective and has shared it with us.
Zen Chu: My purpose was to lend an innovation and new ventures perspective to the FDA panel:
FDA should lend clarity to regulations and exercise restraint to enable new technologies and services to engage patients
FDA needs to distinguish between ads and messages delivered to benefit wellness, compliance, adherence
FDA must hire more expertise in new media and technology to understand and provide more timely guidelines
A
New Media & Technology Advisory Board, comprise of both industry,
academia and patient advocates should be created to advise FDA
18 NOVEMBER 2009, BOSTON - Nice old piece on Socialnomics, which has been seen a lot by now, but with the FDA Public Hearings on Social Media (#FDASM) I think it is appropriate to bring it back and refresh us. The Social Media Revolution...
10 NOVEMBER 2009 - BOSTON It is with a heavy heart that CIMIT says goodbye to our friend and colleague Dr. Don Baim. Don passed away last Friday, 6 November 2009, following complications of surgery to treat adrenal cancer.
We will remember Don as a former CIMIT Site Miner (one of many roles here) and as someone who continually pushed medicine forward -- be it from Harvard Medical to Boston Scientific. He was a Forum speaker, a panelist multiple times and from time to time we found him in the audience of Forums focused on Venture Capitalism in Medicine.
This morning John Parrish called a moment of silence for Don here at CIMIT and we remembered how much he gave to medicine and the better outcomes he helped produce.
Don was a friend to all of us here and his loss is a tremendous one.
Last week headed off to the CIMIT Innovation Congress 2009 in Boston. There we found ourselves at the intersection of academic medicine, government and industry with clinicians and researchers doing groundbreaking work. The conference was a tremendous success with the Focus Session breakouts, the Exploratorium, and the Keynotes. Embedded below you'll find a few great keynotes and links to all the rest.
Clay Christensen Harvard Business School - Talks about Disruptive Innovation and healthcare reform
Maj. General James K. Gilman Commander of Medical Research and Materials Command at Fort Detrick - Tells us how we take care of today's Wounded Warriors
Susan Axelrod President and Founder, CURE - Tells the story of her daughters struggle with Epilepsy
Social Networking and
Knowledge Sharing for Scientists and Researchers
Moderator: Rajiv Gupta,
MD, PHD, Director, VCT Lab and Assistant Radiologist, Department of
Radiology, Massachusetts General Hospital
Sharing Knowledge: Institutional
and Technological Facilitators and Inhibitors
David Lazer, PhD, Associate Professor of Political Science
and Computer Science, Northeastern University & Director, Program
on Networked Governance, Harvard Kennedy School, Harvard University
What are the factors that affect how people search for information,
and in turn, whether others provide information? This presentation will
examine three case studies of information sharing: regarding the use
of DNA in the criminal justice system, regarding the use of the Internet
by members of Congress, and among State Health Officials, focusing on
the questions of what facilitates and inhibits knowledge sharing.
ResearchGATE: A First step
towards Science 2.0 Ijad Madisch, MD, PhD,ResearchGATE CEO and Co-Founder and Researcher in the Department
of Radiology, Massachusetts General Hospital, Harvard University
ResearchGATEis a no-charge, online research platform
focused on the sciences, but open to all disciplines. Improving collaboration
among scientists is the top goal and ResearchGATE offers many tools
to encourage this. First, with its social networking platform, researchers
create profiles, form groups, upload papers and network with each other.
Within the groups, members can use a smart file and data sharing tool
to co-edit documents. For institutions or associations, the platform
offer Subcommunities. These are essentially smaller, (password-)protected
versions of the ResearchGATE platform that are open only to members
of the respective institution. ResearchGATE also assists individual
researchers in managing their literature resources. The platform provides
extensive search capacities - including a semantic search engine into
which entire abstracts can be pasted – that help users locate papers
both within the internal resources and in all major external databases,
including PubMed and CiteSeer. ResearchGATE’s
new Job Board helps
keep members working in the physical world; employment-seekers can find
extensive academic postings here. The team's commitment to serious research
is reflected by its scientific advisory network of more than 140 leading
scientists. Currently, over 150,000 registered scientists from more
than 200 countries form the network.
Alvaro Pascual-Leone,
MD, PHD, Professor in Neurology, Director, Berenson-Allen Center for
Noninvasive Brain Stimulation and Harvard-Thorndike Clinical Research
Center, Harvard Medical School and Beth Israel Deaconess Medical Center
There is no doubt that the current
economic downturn has wreaked havoc in medical device investment. Smaller
device companies are cash strapped, and have little hope to enter the
public market. Venture investors are reluctant to invest as a result;
new regulatory and medical reimbursement issues continue to add complexity
into the mix. The pace of discovery of innovative medical solutions
made in academia remains unchanged, however. Is this a matter of waiting
out the storm, or is there a need for a new model of academic/industrial
relations?
This CIMIT Forum will showcase
the perspectives of diverse stakeholders in the device space: the VC,
the small company CEO, the life sciences entrepreneur, and the academician.
Some of the issues to be explored will include: nature of collaborations
between academia and industry; the maturity level of academic innovations
needed to attract industry attention; and new/creative ways of structuring
alliances/deals.
Recent Comments